The current industry-involved system may present a conflict of interest
More patients, and therefore medical professionals at all levels, are encountering devices that are being remotely monitored. While all currently implanted pacemakers and defibrillators are now remote-monitoring capable, there has also been a substantial increase in the use of implantable loop monitors — from 987 in the 2013–14 financial year to 2269 in 2015–16 (Medicare Benefits Schedule item 38285; http://medicarestatistics.humanservices.gov.au/statistics/mbs_item.jsp). This increase has forced the health care system to engage with remote monitoring.
- 1. Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 2014; 384: 583-590.
- 2. Spencker S, Coban N, Koch L, et al. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace 2009; 11: 483-488.
- 3. Burri H, Sticherling C, Wright D, et al. Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK. Europace 2013; 15: 1601-1608.
- 4. Slotwiner D, Varma N, Akar JG, et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm 2015; 12: e69-e100.
- 5. Lau CP, Zhang S. Remote monitoring of cardiac implantable devices in the Asia-Pacific. Europace 2013; 15 Suppl 1: i65-i68.
- 6. Australian Government Department of Health. Medicare Benefits Schedule book. Operating from 1 July 2016. Canberra: Commonwealth of Australia, 2015. http://www.health.gov.au/internet/mbsonline/publishing.nsf/Content/45CBF3F97BA64FBDCA257FD5000E6666/$File/201607-MBS.pdf (accessed Nov 2016).
- 7. Australian Government Department of Health. The prostheses list. http://www.health.gov.au/internet/main/publishing.nsf/Content/health-privatehealth-prostheseslist.htm (accessed Nov 2016).
- 8. Ricci RP, Vicentini A, D'Onofrio A, et al. Impact of in-clinic follow-up visits in patients with implantable cardioverter defibrillators: demographic and socioeconomic analysis of the TARIFF study population. J Interv Card Electrophysiol 2013; 38: 101-106.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.